Paraneoplastic MCD Hodgkin — ESENeph MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Minimal change disease is a recognised paraneoplastic association with Hodgkin lymphoma
MCD is the most commonly associated paraneoplastic glomerular disease with Hodgkin lymphoma. The mechanism involves tumour-derived cytokines (particularly IL-13) causing podocyte dysfunction. It can occur at diagnosis, during relapse, or even after apparent remission. Treatment is with corticosteroids as for primary MCD, but lymphoma surveillance is essential. If MCD relapses, lymphoma recurrence should be considered and investigated.
Reference: KDIGO 2021 – GN Guideline; Jhaveri et al 2013 – Paraneoplastic GN